Statement
5 Sep 2025
Statement on the publication of the 24th WHO Model List of Essential Medicines
Responding to the publication of the updated WHO Model List of Essential Medicines (EML), IFPMA Director General, Dr. David Reddy said: “The inclusion of innovative medicines on the updated EML highlights how scientific advances are transforming how we prevent, treat and cure disease, and reinforces the importance of ensuring patients everywhere can benefit from them. ...
Read more
Statement
27 Aug 2025
AMATA statement at 75th WHO AFRO: Progress report on the regional strategy on regulation of medical products in African region
On 27 August 2025, the African Medicines Agency Treaty Alliance submitted a statement on agenda item 16.8: Progress report on the regional strategy on regulation of medical products in African region, 2016-2025 at the 75th Session of the WHO Regional Committee for Africa. The African Medicines Agency Treaty Alliance (AMATA) commends the progress made under...
Read more
Statement
27 Aug 2025
75th WHO Regional Committee for Africa: Progress report on the implementation of the strategy for scaling up health innovations in the African region
On 27 August 2025 in Lusaka, Zambia, IFPMA delivered a statement at the 75th session of the WHO Regional Committee for Africa focused on Agenda item 16.2: Progress report on the implementation of the strategy for scaling up health innovations in the African region. IFPMA takes note of WHO AFRO’s Progress report on the implementation...
Read more